According to data from a small, randomized, clinical trial published in the Journal of the American Medical Association, daily use of a supplement containing soy protein isolate for 2 years after radical prostatectomy did not reduce risk for biochemical progression of prostate cancer in high-risk patients. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biochenical, outcome, post-surgery, recurrence, soy, supplement | 8 Comments »
Perhaps the most interesting new data from the annual meeting of the American Society of Clinical Oncology yesterday (Sunday) was a negative result from a four-arm, randomized clinical trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation, Effexor, hot flashes, soy, venlaxafine | 3 Comments »
A new Canadian study just reported in the Journal of Clinical Oncology has failed to find any significant benefit from the use of vitamin E, selenium, and soy protein supplements in the prevention of prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: HG-PIN, high-grade, Prevention, prostatic intraepithelial neoplasia, risk, selenium, soy, vitamin E | 5 Comments »
The idea that the soy isoflavone known as genistein might prove to be a non-toxic therapeutic agent for the prevention and/or treatment of prostate cancer has now been around for so long that the idea appears to have become a perceived truth in some quarters. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer | Tagged: genistein, isoflavone, outcome, soy, trial | Leave a comment »
Soy isoflavones are known to have antioxidant and anti-inflammatory activities and to sensitize prostate cancer cells to radiation therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, complications, isoflavone, radiation therapy, soy | 1 Comment »
We have added information about three more recent studies for your weekend reading, dealing with:
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: bladder neck preservation, chemotherapy, diet, hormone-refractory prostate cancer, nomogram, outcome, Prevention, risk, soy | Leave a comment »
Our second report today deals with:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Prevention, Risk, Uncategorized | Tagged: apolipoprotein, chemotherapy, isoflavone, prognosis, PSA "half-life", sensitization, soy, taxane, VEBSA, vitamin E analog | Leave a comment »
